CB1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CB1 Antibodies for advanced research in cannabinoid receptor studies. Monoclonal CB1 Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The CB1 receptor, primarily found in the brain, plays a crucial role in modulating neurotransmitter release and is involved in numerous physiological processes, including pain sensation, mood regulation, and appetite control. Understanding CB1 receptor function is essential for exploring implications in various neurological disorders and therapeutic interventions. CB1 receptor research has revealed significant insights into neurotransmitter regulation and synaptic plasticity. Recent studies have highlighted the importance of CB1 receptors in memory formation and emotional processing. Ongoing research continues to uncover new roles for CB1 receptors in brain development and neurological health. Santa Cruz Biotechnology monoclonal CB1 Antibodies enable researchers worldwide to advance our understanding of cannabinoid signaling systems.